Sterile Water for Injection
Sponsors
Kezar Life Sciences Inc., Chinese PLA General Hospital, ZhiYong Peng, National Institute of Allergy and Infectious Diseases (NIAID), Dr Cipto Mangunkusumo General Hospital
Conditions
Acute Lung InjuryAlpha-tocopherolAutoimmune diseaseCOVID-19Cardiac SurgeryEye DiseasesPneumonia, Ventilator-AssociatedPneumonia, Viral
Early Phase 1
Phase 1
Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans
WithdrawnNCT06845358
Start: 2025-11-26End: 2026-09-01Updated: 2025-12-17
Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
Active, not recruitingNCT07183709
Start: 2026-02-02End: 2026-08-03Target: 60Updated: 2026-04-03
Phase 2
Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome
NCT01391481
Start: 2011-08-31End: 2015-04-30Target: 200Updated: 2012-04-10
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
TerminatedNCT04264533
Start: 2020-02-14End: 2020-03-29Updated: 2020-10-12
A Phase 2b, Randomized, Controlled Double-blind, Multicenter Study Comparing the Efficacy and Safety of Zetomipzomib (KZR-616) 30 mg or 60 mg with Placebo in Patients with Active Lupus Nephritis
CompletedCTIS2022-502227-22-00
Start: 2023-10-25End: 2024-10-17Target: 82Updated: 2024-04-24
Phase 3
Unknown Phase
A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects with Saphylococcus aureus Bacteremia including infective Endocarditis
Active, not recruitingPER-045-16
Start: 2017-04-07Target: 15Updated: 2023-09-04
Effect of Amikacin-Embeded Humidifier on prevention of circuit colonisation and incidence of early ventilator associated pneumonia in critically ill patients
Active, not recruitingPACTR202202537632410
Start: 2022-03-01Target: 90Updated: 2026-01-27
Effect of Intravenous Calcium Gluconate on Intraoperative Blood Loss During Caesarean Section: A Randomised Controlled Trial at Nnewi
Active, not recruitingPACTR202601807808004
Start: 2026-01-18Target: 220Updated: 2026-01-27